MyFinsight
Home
About
Contact
Back
Income Statement
Caris Life Sciences, Inc. (CAI)
source: myfinsight.com
Download
Download image
Net loss
attributable to common...
-$517,197K
Net loss
attributable to common...
-$517,197K
Net income (loss)
-$71,790K
Adjustments of redeemable
convertible preferred stock...
$60,971K
Deemed dividend from
series d redeemable...
$384,436K
Loss before income
taxes and provision...
-$71,790K
US
$178,177K
Non Us
$3,221K
Total other income
(expense), net
-$53,801K
Loss from operations
-$17,989K
Interest income
$1,618K
Total revenue
$181,398K
Changes in fair value of
financial instruments
-$17,870K
Interest expense
$19,208K
Other expense, net
-$18,341K
Total costs and
operating expenses
$199,387K
Cost of
services-Molecular Profiling...
$65,321K
Cost of
services-Pharma Research And...
$2,392K
General and
administrative expense (see...
$64,367K
Research and development
expense
$25,047K
Selling and marketing
expense
$42,260K
Back